US5258402A
(en)
|
1992-06-11 |
1993-11-02 |
Mcneil-Ppc, Inc. |
Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
|
US5384327A
(en)
*
|
1992-12-22 |
1995-01-24 |
Mcneilab, Inc. |
Anticonvulsant sorbopyranose sulfamates
|
NZ277725A
(en)
*
|
1993-12-23 |
1998-04-27 |
Ortho Pharma Corp |
Pseudofructopyranose sulphamate derivatives, preparation and pharmaceutical compositions thereof
|
US5998380A
(en)
*
|
1995-10-13 |
1999-12-07 |
New England Medical Center Hospitals, Inc. |
Treatment of migraine
|
ES2184127T3
(es)
*
|
1996-06-28 |
2003-04-01 |
Ortho Mcneil Pharm Inc |
Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad.
|
WO2000050020A2
(en)
|
1999-02-24 |
2000-08-31 |
University Of Cincinnati |
Use of sulfamate derivatives for treating impulse control disorders
|
US6583172B1
(en)
*
|
1999-04-08 |
2003-06-24 |
Richard P. Shank |
Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
|
CA2369091C
(en)
*
|
1999-04-08 |
2005-01-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful in lowering blood pressure
|
US7056890B2
(en)
|
1999-06-14 |
2006-06-06 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
US7659256B2
(en)
*
|
1999-06-14 |
2010-02-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
US7674776B2
(en)
*
|
1999-06-14 |
2010-03-09 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
US20080103179A1
(en)
*
|
2006-10-27 |
2008-05-01 |
Tam Peter Y |
Combination Therapy
|
US7553818B2
(en)
*
|
1999-06-14 |
2009-06-30 |
Vivus, Inc. |
Combination therapy for effecting weight loss and treating obesity
|
US20080255093A1
(en)
*
|
1999-06-14 |
2008-10-16 |
Tam Peter Y |
Compositions and methods for treating obesity and related disorders
|
US6495523B1
(en)
*
|
1999-07-26 |
2002-12-17 |
Ortho Mcneil-Pharmaceutical, Inc. |
Tricyclic monosaccharide derivatives useful in treating acute ischemia-induced neurodegeneration
|
CN101404993A
(zh)
*
|
2000-07-07 |
2009-04-08 |
奥索-麦克尼尔药品公司 |
用于预防ii型糖尿病和x综合征的发展的抗惊厥剂衍生物
|
AU2001280865A1
(en)
|
2000-08-02 |
2002-02-13 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivatives useful for the treatment of depression
|
AU2002253838B2
(en)
*
|
2000-10-30 |
2006-11-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Combination therapy comprising anti-diabetic and anticonvulsant agents
|
KR100896971B1
(ko)
*
|
2001-02-02 |
2009-05-14 |
오르토-맥네일 파마슈티칼, 인코퍼레이티드 |
프락토피라노오스 설파메이트 및 에리트로포이에틴을포함하는 신경계 기능장애 치료법
|
UA78211C2
(en)
*
|
2001-07-09 |
2007-03-15 |
Ortho Mcneil Pharm Inc |
Salts of fructopyranose derivatives as anticonvulsant
|
US7041650B2
(en)
*
|
2001-07-09 |
2006-05-09 |
Ortho-Mcneil Pharmaceutical, Inc. |
Anticonvulsant derivative salts
|
EP1450826A1
(en)
*
|
2001-11-06 |
2004-09-01 |
Ortho-Mcneil Pharmaceutical Corp. |
Treatment and prevention of paresthesia comprising co-therapy with anticonvulsant derivatives and potassium
|
US7927613B2
(en)
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US20050025791A1
(en)
*
|
2002-06-21 |
2005-02-03 |
Julius Remenar |
Pharmaceutical compositions with improved dissolution
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US6559293B1
(en)
|
2002-02-15 |
2003-05-06 |
Transform Pharmaceuticals, Inc. |
Topiramate sodium trihydrate
|
WO2003074474A2
(en)
|
2002-03-01 |
2003-09-12 |
University Of South Florida |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
IL163720A0
(en)
*
|
2002-02-26 |
2005-12-18 |
Ortho Mcneil Pharm Inc |
Co-therapy for the treatment of migraine comprising anticonvulsant derivatives and anti-migraine agents
|
US7060725B2
(en)
*
|
2002-05-13 |
2006-06-13 |
Janssen Pharmaceutica N.V. |
Substituted sulfamate anticonvulsant derivatives
|
US20070059356A1
(en)
*
|
2002-05-31 |
2007-03-15 |
Almarsson Oern |
Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen
|
US7196209B2
(en)
*
|
2002-10-31 |
2007-03-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Continuous process for the preparation of fructopyranose sulfamate derivatives
|
US8183290B2
(en)
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
MY147767A
(en)
*
|
2004-06-16 |
2013-01-31 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
TW200612905A
(en)
*
|
2004-06-16 |
2006-05-01 |
Janssen Pharmaceutica Nv |
Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders
|
CA2578407A1
(en)
*
|
2004-08-24 |
2006-03-02 |
Janssen Pharmaceutica N.V. |
Novel benzo-fused heteroaryl sulfamide derivatives useful as anticonvulsant agents
|
EP1881959A1
(en)
*
|
2005-05-20 |
2008-01-30 |
Janssen Pharmaceutica N.V. |
Process for preparation of sulfamide derivatives
|
EP1937646A1
(en)
|
2005-09-23 |
2008-07-02 |
Janssen Pharmaceutica N.V. |
Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
|
NZ567006A
(en)
*
|
2005-09-23 |
2010-11-26 |
Janssen Pharmaceutica Nv |
Hexahydro cyclooctyl pyrazole cannabinoid modulators
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
KR20080050522A
(ko)
*
|
2005-09-23 |
2008-06-05 |
얀센 파마슈티카 엔.브이. |
헥사하이드로-사이클로헵타피라졸 카나비노이드 모듈레이터
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
US20070155824A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
|
US20070155823A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives as neuroprotective agents
|
US8937096B2
(en)
|
2005-12-19 |
2015-01-20 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder
|
US8691867B2
(en)
*
|
2005-12-19 |
2014-04-08 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
|
US8716231B2
(en)
|
2005-12-19 |
2014-05-06 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain
|
US8497298B2
(en)
*
|
2005-12-19 |
2013-07-30 |
Janssen Pharmaceutica Nv |
Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels
|
US20070155827A1
(en)
*
|
2005-12-19 |
2007-07-05 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression
|
US8492431B2
(en)
*
|
2005-12-19 |
2013-07-23 |
Janssen Pharmaceutica, N.V. |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of obesity
|
WO2007092456A2
(en)
*
|
2006-02-03 |
2007-08-16 |
Rolls-Royce Corporation |
Gas turbine engine fuel system with fuel metering valve
|
US7795294B2
(en)
*
|
2006-02-14 |
2010-09-14 |
Janssen Pharmaceutica N.V. |
Tetrahydro-2H-indazole pyrazole cannabinoid modulators
|
US20070191449A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Depression
|
US20070191451A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives as neuroprotective agents
|
US20070191461A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of migraine
|
US20070191459A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for Lowering Lipids and Lowering Blood Glucose Levels
|
US20070191453A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-heteroaryl sulfamide derivatives for the treatment of substance abuse and addiction
|
US20070191450A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Mania and Bipolar Disorder
|
US20070191474A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of benzo-fused heterocyle sulfamide derivatives for the treatment of migraine
|
US20070191460A1
(en)
*
|
2006-02-15 |
2007-08-16 |
Smith-Swintosky Virginia L |
Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis
|
WO2007112402A1
(en)
*
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
JP2009537635A
(ja)
*
|
2006-05-19 |
2009-10-29 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
癲癇の処置のための共同−療法
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
US20090247617A1
(en)
*
|
2008-03-26 |
2009-10-01 |
Abdel-Magid Ahmed F |
Process for the preparation of benzo-fused heteroaryl sulfamates
|
US8580298B2
(en)
|
2008-06-09 |
2013-11-12 |
Vivus, Inc. |
Low dose topiramate/phentermine composition and methods of use thereof
|
US20090304789A1
(en)
|
2008-06-09 |
2009-12-10 |
Thomas Najarian |
Novel topiramate compositions and an escalating dosing strategy for treating obesity and related disorders
|
BRPI0915890A2
(pt)
|
2008-06-23 |
2015-11-03 |
Janssen Pharmaceutica Nv |
forma cristalina de (2s)-(-)-n-(6-cloro-2,3-di-hidro-benzo[1,4]dioxin-2-ilmetil)-sulfamida
|
US8815939B2
(en)
*
|
2008-07-22 |
2014-08-26 |
Janssen Pharmaceutica Nv |
Substituted sulfamide derivatives
|
NL2021840B1
(en)
|
2018-10-19 |
2020-05-13 |
Univ Leiden |
Pharmacological Chaperones For Enzyme Treatment Therapy
|
WO2020046132A1
(en)
|
2018-08-31 |
2020-03-05 |
Leiden University |
Pharmacological chaperones for enzyme treatment therapy
|